ATE56953T1 - 1-((aminoalkyl und aminoalkylamino)carbonyl und thiocarbonyl> alpha,alpha-diarylpyrrolidin, piperidin und homopiperidinacetamide und acetonitrile. - Google Patents
1-((aminoalkyl und aminoalkylamino)carbonyl und thiocarbonyl> alpha,alpha-diarylpyrrolidin, piperidin und homopiperidinacetamide und acetonitrile.Info
- Publication number
- ATE56953T1 ATE56953T1 AT85307559T AT85307559T ATE56953T1 AT E56953 T1 ATE56953 T1 AT E56953T1 AT 85307559 T AT85307559 T AT 85307559T AT 85307559 T AT85307559 T AT 85307559T AT E56953 T1 ATE56953 T1 AT E56953T1
- Authority
- AT
- Austria
- Prior art keywords
- alpha
- aminoalkylamino
- acetonitriles
- thiocarbonyl
- aminoalkyl
- Prior art date
Links
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title abstract 4
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 title 1
- -1 HOMOPIPERIDINE ACETAMIDES Chemical class 0.000 title 1
- DXHPZXWIPWDXHJ-UHFFFAOYSA-N carbon monosulfide Chemical class [S+]#[C-] DXHPZXWIPWDXHJ-UHFFFAOYSA-N 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- SGNIOVNJCXQXOD-UHFFFAOYSA-N 2-(azepan-1-yl)acetamide Chemical class NC(=O)CN1CCCCCC1 SGNIOVNJCXQXOD-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Chemical group 0.000 abstract 1
- 125000005122 aminoalkylamino group Chemical group 0.000 abstract 1
- 230000003288 anthiarrhythmic effect Effects 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/662,583 US4594343A (en) | 1984-10-19 | 1984-10-19 | 1-[(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl]-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles |
| EP85307559A EP0178947B1 (de) | 1984-10-19 | 1985-10-18 | 1-[(Aminoalkyl und Aminoalkylamino)carbonyl und Thiocarbonyl] alpha,alpha-Diarylpyrrolidin, Piperidin und Homopiperidinacetamide und Acetonitrile |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE56953T1 true ATE56953T1 (de) | 1990-10-15 |
Family
ID=24658311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85307559T ATE56953T1 (de) | 1984-10-19 | 1985-10-18 | 1-((aminoalkyl und aminoalkylamino)carbonyl und thiocarbonyl> alpha,alpha-diarylpyrrolidin, piperidin und homopiperidinacetamide und acetonitrile. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4594343A (de) |
| EP (1) | EP0178947B1 (de) |
| JP (1) | JPS61100563A (de) |
| KR (1) | KR900001204B1 (de) |
| AT (1) | ATE56953T1 (de) |
| AU (1) | AU584931B2 (de) |
| CA (1) | CA1242439A (de) |
| DE (1) | DE3579883D1 (de) |
| IL (1) | IL76586A (de) |
| PH (1) | PH21991A (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0177078A1 (de) * | 1984-09-12 | 1986-04-09 | Duphar International Research B.V | Spasmolytisch wirksame tertiäre Aminderivate und Verfahren zu ihrer Herstellung |
| US4960776A (en) * | 1987-01-28 | 1990-10-02 | A. H. Robins Company, Inc. | 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides |
| DE3744024A1 (de) * | 1987-12-24 | 1989-07-06 | Hoechst Ag | Fluessigkristalline, in 1-stellung substituierte piperidin-4-carbonsaeureester, verfahren zu ihrer herstellung und ihre verwendung in fluessigkristallinen mischungen |
| US5932594A (en) * | 1988-11-01 | 1999-08-03 | Pfizer, Inc. | Muscarinic receptor antagonists |
| GB8825505D0 (en) * | 1988-11-01 | 1988-12-07 | Pfizer Ltd | Therapeutic agents |
| GB8906166D0 (en) * | 1989-03-17 | 1989-05-04 | Pfizer Ltd | Therapeutic agents |
| US5169855A (en) * | 1990-03-28 | 1992-12-08 | Du Pont Merck Pharmaceutical Company | Piperidine ether derivatives as psychotropic drugs or plant fungicides |
| JP4057088B2 (ja) * | 1996-04-22 | 2008-03-05 | 株式会社カネカ | ピロリジン誘導体の製造方法 |
| US6693202B1 (en) | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
| TW200800953A (en) * | 2002-10-30 | 2008-01-01 | Theravance Inc | Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine |
| JP4767842B2 (ja) * | 2003-04-01 | 2011-09-07 | セラヴァンス， インコーポレーテッド | β２アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有するジアリールメチル化合物および関連化合物 |
| TW200510298A (en) * | 2003-06-13 | 2005-03-16 | Theravance Inc | Substituted pyrrolidine and related compounds |
| JP2007524641A (ja) * | 2003-07-11 | 2007-08-30 | セラヴァンス， インコーポレーテッド | 置換４−アミノ−１−ベンジルピペリジン化合物 |
| EP1723142A1 (de) * | 2004-03-11 | 2006-11-22 | Theravance, Inc. | Als antagonisten des muskarinrezeptors geeignete diphenylmethylverbindungen |
| EP1725525A1 (de) * | 2004-03-11 | 2006-11-29 | Theravance, Inc. | Als muscarinrezeptorantagonisten geeignete diphenylmethylverbindungen |
| BRPI0516132A (pt) | 2004-10-07 | 2007-12-04 | Vitae Pharmaceuticals Inc | compostos, composição destes, método de antagonização de uma ou mais proteases aspárticas e método para tratar ou melhorar um distúrbio mediado por protease aspártica |
| TWI411607B (zh) * | 2005-11-14 | 2013-10-11 | Vitae Pharmaceuticals Inc | 天門冬胺酸蛋白酶抑制劑 |
| CL2007002689A1 (es) | 2006-09-18 | 2008-04-18 | Vitae Pharmaceuticals Inc | Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras. |
| CN101983187A (zh) * | 2008-04-02 | 2011-03-02 | 株式会社钟化 | (s)-3-(1-氰基-1，1-二苯基甲基)吡咯烷的制备方法 |
| EP2236509A1 (de) | 2009-04-01 | 2010-10-06 | Ragactives, S.L. | Methode zur Herstellung von 1,3-difunktionalisierten Pyrrolidin-Derivaten |
| AR077692A1 (es) | 2009-08-06 | 2011-09-14 | Vitae Pharmaceuticals Inc | Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2409829A (en) * | 1944-04-04 | 1946-10-22 | Ici Ltd | Alkylene-bis-ureas |
| NL88063C (de) * | 1950-12-05 | |||
| US2654754A (en) * | 1950-12-16 | 1953-10-06 | American Home Prod | Substituted glycinamides |
| US3109845A (en) * | 1960-02-04 | 1963-11-05 | Thomae Gmbh Dr K | 1-cyclohexyl, 1-cyclohexenyl, 1-furyl, and 1-thienyl, tertiary amino substituted methanes |
| US3247222A (en) * | 1962-12-26 | 1966-04-19 | Robins Co Inc A H | Alpha (nu-hydrocarbonpyrrolidyl-3-) alpha, alpha carbocyclic arylacetamides |
| GB1057145A (en) * | 1963-08-16 | 1967-02-01 | Bellon Labor Sa Roger | Phenylcyclohexylacetonitrile derivatives |
| GB1178400A (en) * | 1966-12-13 | 1970-01-21 | Delalande Sa | Nitrogen Substituted Amines and their process of Preparation. |
| US3585204A (en) * | 1968-09-19 | 1971-06-15 | Searle & Co | Alpha,alpha-diphenylpiperidineacetic acids and congeners |
| US4017630A (en) * | 1970-08-17 | 1977-04-12 | The Upjohn Company | Certain diphenylalkanoamides used as bird and murine repellents |
| US3998965A (en) * | 1973-12-15 | 1976-12-21 | Aspro-Nicholas Limited | 4-Aminoalkyl-4-cyano-4-phenyl-butanoic acid esters |
| US4361573A (en) * | 1974-03-04 | 1982-11-30 | Temmler Ag | α,α-Diaryl-β-(tert-amino)-propanols and diuretic pharmaceutical compositions containing them |
| US3987201A (en) * | 1974-12-24 | 1976-10-19 | Eli Lilly And Company | Method for treating arrhythmia |
| US4002766A (en) * | 1974-12-26 | 1977-01-11 | A. H. Robins Company, Incorporated | Antiarrhythmia methods |
| GB2002748B (en) * | 1977-05-23 | 1982-01-06 | Ici Ltd | Cardiac stimulants |
| US4277471A (en) * | 1979-03-12 | 1981-07-07 | Eli Lilly And Company | 1,1-Biphenyl-2-yl alkylamines, formulations and antiarrhythmic treatment |
| EP0085286B1 (de) * | 1981-12-17 | 1986-04-30 | Aktiebolaget Hässle | Para-substituierte 3-Phenoxy-1-carbonylaminoalkylaminopropan-2-ole mit blockierenden Wirkungen bei Betarezeptoren |
-
1984
- 1984-10-19 US US06/662,583 patent/US4594343A/en not_active Expired - Fee Related
-
1985
- 1985-10-04 IL IL76586A patent/IL76586A/xx unknown
- 1985-10-16 PH PH32936A patent/PH21991A/en unknown
- 1985-10-18 CA CA000493333A patent/CA1242439A/en not_active Expired
- 1985-10-18 KR KR1019850007676A patent/KR900001204B1/ko not_active Expired
- 1985-10-18 AT AT85307559T patent/ATE56953T1/de not_active IP Right Cessation
- 1985-10-18 EP EP85307559A patent/EP0178947B1/de not_active Expired - Lifetime
- 1985-10-18 AU AU48907/85A patent/AU584931B2/en not_active Ceased
- 1985-10-18 DE DE8585307559T patent/DE3579883D1/de not_active Expired - Fee Related
- 1985-10-19 JP JP60234392A patent/JPS61100563A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU584931B2 (en) | 1989-06-08 |
| CA1242439A (en) | 1988-09-27 |
| JPS61100563A (ja) | 1986-05-19 |
| US4594343A (en) | 1986-06-10 |
| PH21991A (en) | 1988-05-02 |
| AU4890785A (en) | 1986-04-24 |
| EP0178947B1 (de) | 1990-09-26 |
| KR860003221A (ko) | 1986-05-21 |
| EP0178947A3 (en) | 1987-09-02 |
| IL76586A (en) | 1988-09-30 |
| EP0178947A2 (de) | 1986-04-23 |
| DE3579883D1 (de) | 1990-10-31 |
| KR900001204B1 (ko) | 1990-02-28 |
| IL76586A0 (en) | 1986-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU584931B2 (en) | 1-``(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl``-``,``-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles | |
| TW288011B (de) | ||
| BG102162A (en) | Substituted (sulpphinic acid, sulphonic acid, sulphonylamino or sulphinylamino)n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylam ide compounds | |
| MY105136A (en) | Optically active pyridonecarboxylic acid derivatives. | |
| EP0178946A3 (de) | 1-(Aminoalkyl)-alpha, alpha-diaryl-pyrrolidin-, -piperidin- und -homopiperidinacetamide und -acetonitrile | |
| ES2126636T3 (es) | Derivados del bencimidazol con actividad antidiabetica y antiagregante plaquetaria. | |
| ES8501362A1 (es) | Un procedimiento para la preparacion de nuevos derivados arilfenolicos. | |
| ATE66675T1 (de) | Stickstoffhaltige heterozyklische verbindungen. | |
| EP0609441A4 (en) | Oxazolidone derivative. | |
| HUT49847A (en) | Fungicides comprising n-(phenylalkyl)-benzamide derivatives as active ingredient | |
| DE69426620D1 (de) | Antidepressiva | |
| GB8531160D0 (en) | Organic compounds | |
| DK662189D0 (da) | Pyridinylcarbazolaminer, deres fremstilling og anvendelse som laegemidler | |
| UA41936C2 (uk) | 2-[[1-[4-(4-фторфенокси)бутил]-4-піперидиніл]метиламіно]бензотіазололи, призначені для використання в медицині як антиаритмічні засоби ііі класу, спосіб їх одержання і антиаритмічна композиція | |
| ES8303308A1 (es) | "un procedimiento para preparar derivados de urea y tiourea". | |
| EP0337334A3 (de) | Renininhibierende Aminosäurederivate | |
| EP0309841A3 (de) | Aminosäurederivate | |
| EP0160436A3 (de) | N-[(Amino)Alkyl]-1-Pyrrolidine, 1-Piperidine und 1-Homopiperidinecarboxamide (und Thiocarboxamide) mit Schwefelbindung in 2,3 oder 4-Stellung | |
| DK558885A (da) | Oxoisoxazolidinderivater og laegemiddelpraeparat indeholdende dem | |
| EP0371390A3 (de) | Aminosäurederivate | |
| DK42784A (da) | Pyridin-pyrimidinon-derivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser | |
| DE68910736D1 (de) | Fungizide heterozyklische Stickstoffverbindungen. | |
| GB2182934B (en) | Piperidine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |